Hormone therapy for prostate cancer is, metabolically speaking, a kind of managed catastrophe. Within months of starting androgen deprivation treatment, men begin gaining weight, losing muscle, accumulating fat around the abdomen. Blood sugar climbs. Cardiovascular risk rises. The treatments work, often very well, but the body they work in pays a substantial price. And here is the particular crue…
Many biopsies may soon be avoidable with the advent of an accurate biosensor for prostate cancer that detects biomarkers in the blood. The post When diagnosing prostate cancer, two biomarkers are better than one appeared first on Advanced Science News .
